Remember the first cellphone you saw? It looked like an electronic brick, died after a couple of hours and only did one thing: transmit conversations.

STAAR Surgical Receives Approval to Market Visian(R) Toric Implantable Collamer Lens in China

MONROVIA, Calif. (Map) - MONROVIA, Calif., Feb. 29 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced it has received approval from the State Food and Drug Administration of the People's Republic of China (SFDA) to market the STAAR Visian(TM) Toric Implantable Collamer Lens to ophthalmologists and other eye care professionals in the country for the treatment of nearsightedness and astigmatism. In addition the SFDA granted approval to STAAR to market the STAAR Visian ICH, an implantable collamer lens to correct hyperopia or farsightedness.

"This approval has significant strategic importance for STAAR and positions us for continued growth in China," said Barry G.

Calvin Brock Update!

In December 2007 heavyweight contender Calvin Brock underwent surgery to repair retinal damage in his right eye. In response to questions from the media and fans about his return to the ring, Brock has released this statement: "I have been asked by members of the media and by boxing fans when I will return to the ring," said Brock. "Recently I underwent surgery to fix damage in the retina of my right eye and I am waiting for the damage to heal. I plan to return to the ring once my eye is 100%. Until then I will rest and do what is necessary to help my eye repair."

All contents copyright 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007 by Freitag Marketing Services. The information on this site cannot be reused without written permission.